Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus.

Cathelicidins are a family of peptides thought to provide an innate defensive barrier against a variety of potential microbial pathogens. The human and mouse cathelicidins (LL-37 and CRAMP, respectively) are expressed at select epithelial interfaces where they have been proposed to kill a number of gram-negative and gram-positive bacteria. To determine if these peptides play a part in the protection of skin against wound infections, the anti-microbial activity of LL-37 and CRAMP was determined against the common wound pathogen group A Streptococcus, and their expression was examined after cutaneous injury. We observed a large increase in the expression of cathelicidins in human and murine skin after sterile incision, or in mouse following infection by group A Streptococcus. The appearance of cathelicidins in skin was due to both synthesis within epidermal keratinocytes and deposition from granulocyctes that migrate to the site of injury. Synthesis and deposition in the wound was accompanied by processing from the inactive prostorage form to the mature C-terminal peptide. Analysis of anti-microbial activity of this C-terminal peptide against group A Streptococcus revealed that both LL-37 and CRAMP potently inhibited bacterial growth. Action against group A Streptococcus occurred in conditions that typically abolish the activity of anti-microbial peptides against other organisms. Thus, cathelicidins are well suited to provide defense against infections due to group A Streptococcus, and represent an important element of cutaneous innate immunity.

[1]  E. Greenberg,et al.  Bactericidal Activity of Mammalian Cathelicidin-Derived Peptides , 2000, Infection and Immunity.

[2]  Albert Balows,et al.  Manual of Clinical Microbiology, 7th ed. , 2000 .

[3]  G. H. Gudmundsson,et al.  Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. , 1999, Journal of immunological methods.

[4]  J. Johansson,et al.  Porcine pulmonary surfactant preparations contain the antibacterial peptide prophenin and a C‐terminal 18‐residue fragment thereof , 1999, FEBS letters.

[5]  S. Boscolo,et al.  Novel cathelicidins in horse leukocytes , 1999 .

[6]  C. Ross,et al.  PR-39, a proline/arginine-rich antimicrobial peptide, prevents postischemic microvascular dysfunction. , 1999, American journal of physiology. Heart and circulatory physiology.

[7]  R I Lehrer,et al.  Antibiotic peptides from higher eukaryotes: biology and applications. , 1999, Molecular medicine today.

[8]  H. Jörnvall,et al.  Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. , 1999, American journal of respiratory and critical care medicine.

[9]  C. Ross,et al.  Cathelicidin Gene Expression in Porcine Tissues: Roles in Ontogeny and Tissue Specificity , 1999, Infection and Immunity.

[10]  J. Johansson,et al.  Apolipoprotein A-I Binds and Inhibits the Human Antibacterial/Cytotoxic Peptide LL-37* , 1998, The Journal of Biological Chemistry.

[11]  R. Gallo,et al.  Antimicrobial peptides: an emerging concept in cutaneous biology. , 1998, The Journal of investigative dermatology.

[12]  R. Gennaro,et al.  Cytotoxicity and apoptosis mediated by two peptides of innate immunity. , 1998, Cellular immunology.

[13]  Alan J. Waring,et al.  Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils , 1998, Antimicrobial Agents and Chemotherapy.

[14]  R. Bals,et al.  The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Ganz,et al.  The Role of Protegrins and Other Elastase-Activated Polypeptides in the Bactericidal Properties of Porcine Inflammatory Fluids , 1998, Infection and Immunity.

[16]  H. G. Boman,et al.  Gene‐Encoded Peptide Antibiotics and the Concept of Innate Immunity: An Update Review , 1998, Scandinavian journal of immunology.

[17]  D. Low,et al.  Reduced Virulence of Group A Streptococcal Tn916 Mutants That Do Not Produce Streptolysin S , 1998, Infection and Immunity.

[18]  K. Berndt,et al.  Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37* , 1998, The Journal of Biological Chemistry.

[19]  D. Burkin,et al.  Localization and genomic organization of sheep antimicrobial peptide genes. , 1998, Gene.

[20]  V. Nizet,et al.  Invasion of brain microvascular endothelial cells by group B streptococci , 1997 .

[21]  M. Zanetti,et al.  Structural organization of the bovine cathelicidin gene family and identification of a novel member 1 , 1997, FEBS letters.

[22]  D. Bainton,et al.  The Human Antibacterial Cathelicidin, hCAP-18, Is Synthesized in Myelocytes and Metamyelocytes and Localized to Specific Granules in Neutrophils , 1997 .

[23]  M. Ackermann,et al.  Epithelial antibiotic induced in states of disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Schröder,et al.  A peptide antibiotic from human skin , 1997, Nature.

[25]  H. Wigzell,et al.  The Expression of the Gene Coding for the Antibacterial Peptide LL-37 Is Induced in Human Keratinocytes during Inflammatory Disorders* , 1997, The Journal of Biological Chemistry.

[26]  C. Kozak,et al.  Identification of CRAMP, a Cathelin-related Antimicrobial Peptide Expressed in the Embryonic and Adult Mouse* , 1997, The Journal of Biological Chemistry.

[27]  C. Ross,et al.  Chemoattractant properties of PR‐39, a neutrophil antibacterial peptide , 1997, Journal of leukocyte biology.

[28]  James M. Wilson,et al.  Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis , 1997, Cell.

[29]  D. Bainton,et al.  The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. , 1997, Blood.

[30]  R. Gibson,et al.  Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells , 1996, Infection and immunity.

[31]  C. Ross,et al.  PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Odeberg,et al.  The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. , 1996, European journal of biochemistry.

[33]  H. G. Boman.  Peptide Antibiotics: Holy or Heretic Grails of Innate Immunity? , 1996, Scandinavian journal of immunology.

[34]  D. Bessen,et al.  Genetic correlates of throat and skin isolates of group A streptococci. , 1996, The Journal of infectious diseases.

[35]  H. Jörnvall,et al.  Biochemical and antibacterial analysis of human wound and blister fluid. , 1996, European journal of biochemistry.

[36]  Domenico Romeo,et al.  Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain , 1995, FEBS letters.

[37]  J. Odeberg,et al.  FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Ross,et al.  Identification of a proline‐arginine‐rich antibacterial peptide from neutrophils that is analogous to PR‐39, an antibacterial peptide from the small intestine , 1994, Journal of leukocyte biology.

[39]  M. Klagsbrun,et al.  Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  C. Bevins.  Antimicrobial peptides as agents of mucosal immunity. , 1994, Ciba Foundation symposium.

[41]  J. Cavaillon,et al.  A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. , 1994, Journal of immunology.

[42]  R I Lehrer,et al.  Defensins: antimicrobial and cytotoxic peptides of mammalian cells. , 1993, Annual review of immunology.

[43]  Douglas E. Jones,et al.  Paneth cells of the human small intestine express an antimicrobial peptide gene. , 1992, The Journal of biological chemistry.

[44]  Wayne L. Smith,et al.  Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. , 1992, The Journal of biological chemistry.

[45]  V. Mutt,et al.  Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. , 1991, European journal of biochemistry.

[46]  J. Ferretti,et al.  Electrotransformation of Streptococcus pyogenes with plasmid and linear DNA. , 1991, FEMS microbiology letters.

[47]  H. Horstmann,et al.  Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in the large granules , 1990, The Journal of cell biology.

[48]  C. E. Ooi,et al.  Isolation of two isoforms of a novel 15-kDa protein from rabbit polymorphonuclear leukocytes that modulate the antibacterial actions of other leukocyte proteins. , 1990, The Journal of biological chemistry.

[49]  V. Fischetti,et al.  A human IgG receptor of group A streptococci is associated with tissue site of infection and streptococcal class. , 1990, The Journal of infectious diseases.

[50]  M. Zasloff,et al.  Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[51]  M. Zasloff,et al.  Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor , 1987 .

[52]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[53]  T. Ganz,et al.  DEFENSINS: NATURAL PEPTIDE ANTIBIOTICS IN HUMAN NEUTROPHILS , 1986 .